The Covid-19 relief bill that the U.S. Congress expects to pass today has more funds for an international group distributing vaccines to low-resource regions. . . . → Read More: Global Vaccine Funds in Covid-19 Relief Bill
|
|||||
The Covid-19 relief bill that the U.S. Congress expects to pass today has more funds for an international group distributing vaccines to low-resource regions. . . . → Read More: Global Vaccine Funds in Covid-19 Relief Bill A survey this month shows growing acceptance of Covid-19 vaccines across racial and ethnic lines, with Black Americans somewhat less willing than White or Hispanic Americans. . . . → Read More: Infographic – Vaccine Support Grows Across Ethnic Lines A biotechnology company and university infectious disease lab are developing a Covid-19 vaccine given as a solid dose implant under the skin. . . . → Read More: Univ. Lab, Biotech Partner on Covid-19 Vaccine Implant A clinical trial conducted by National Institutes of Health is evaluating two more synthetic antibodies as treatments for patients hospitalized with Covid-19 infections. . . . → Read More: Large Trial Testing Covid-19 Antibody Therapies A digital health company is partnering with a cardiologist group to capture data from smartphones and wearable devices to provide users personalized heart health information. . . . → Read More: Fitness, Phone Data Captured for Heart Health Project A three year-old biotechnology company developing treatments for psychiatric and movement disorders is being acquired by global drug maker Novartis. . . . → Read More: Neuroscience Biotech Acquired in $770M Deal A medical device developer is receiving a Gates Foundation grant for a simple test to detect Covid-19 infections, done completely at home. . . . → Read More: Gates Funding Home-Based Crispr Covid-19 Diagnostic A clinical trial is underway assessing an implanted ultrasound device with chemotherapy to treat glioblastoma, an aggressive form of brain cancer. . . . → Read More: Trial Testing Ultrasound, Chemo for Brain Tumors Results from an early clinical trial of stem cells to treat amyotrophic lateral sclerosis, or ALS, shows the therapy is safe and slows progression of the disease. . . . → Read More: ALS Stem Cell Treatments Found Safe, Slow Progression Drug maker AbbVie is licensing a synthetic antibody to treat Covid-19 and SARS coronaviruses that the company began funding in June. . . . → Read More: AbbVie Acquires Coronavirus Antibody Therapy |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |